Exelixis Announces Second Quarter 2021 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Exelixis Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Exelixis (EXEL) PT Raised to $30 at Oppenheimer

August 6, 2021 10:36 AM EDT

Oppenheimer analyst Silvan Tuerkcan raised the price target on Exelixis (NASDAQ: EXEL) to $30.00 (from $27.00) while maintaining an Outperform rating.

The analyst commented, "EXEL provided 2Q financial results featuring record Cabo sales of $284.2M with continued uptake of nivo + cabo in 1L RCC following FDA... More

Exelixis (EXEL) Tops Q2 EPS by 30c

August 5, 2021 4:25 PM EDT

Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.37, $0.30 better than the analyst estimate of $0.07. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $298.16 million.

GUIDANCE:

Exelixis sees FY2021 revenue of $1.3-1.4 billion, versus the consensus of $1.23... More